Kang W, Yang S, Roh J, Choi D, Lee H, Lee J
FASEB J. 2024; 38(20):e70107.
PMID: 39417398
PMC: 11580716.
DOI: 10.1096/fj.202401468RR.
Engin A
Adv Exp Med Biol. 2024; 1460:131-166.
PMID: 39287851
DOI: 10.1007/978-3-031-63657-8_5.
Miranda J, Key Wakate Teruya A, Leao Filho H, Lahan-Martins D, Tamura Sttefano Guimaraes C, de Paula Reis Guimaraes V
Abdom Radiol (NY). 2024; 49(12):4437-4462.
PMID: 38896247
DOI: 10.1007/s00261-024-04407-4.
Funuyet-Salas J, Martin-Rodriguez A, Perez-San-Gregorio M, Vale L, Robinson T, Anstee Q
PLoS One. 2024; 19(5):e0300362.
PMID: 38709751
PMC: 11073709.
DOI: 10.1371/journal.pone.0300362.
Rishi J, Timme K, White H, Kerns K, Keating A
Biol Reprod. 2024; 111(2):483-495.
PMID: 38625059
PMC: 11327319.
DOI: 10.1093/biolre/ioae059.
Integrative proteomics and metabolomics explore the effect and mechanism of Qiyin granules on improving nonalcoholic fatty liver disease.
Yan X, Liu H, Huang M, Zhang Y, Zeng B
Heliyon. 2024; 10(5):e27075.
PMID: 38444462
PMC: 10912341.
DOI: 10.1016/j.heliyon.2024.e27075.
Comparing Efficacy and Safety of Different Doses of Tirzepatide for the Treatment of Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials.
Khan Z, Naeem M, Khan S, Khan F, Abdullah M, Attique I
Cureus. 2023; 15(8):e44314.
PMID: 37779743
PMC: 10536403.
DOI: 10.7759/cureus.44314.
Effects of Fermented L. and L. on Inhibition of Obesity In Vitro and In Mice.
On J, Kim S, Kim J, Park S, Kim K, Lee C
Nutrients. 2023; 15(9).
PMID: 37432154
PMC: 10180564.
DOI: 10.3390/nu15092022.
Association of the android to gynoid fat ratio with nonalcoholic fatty liver disease: a cross-sectional study.
Yang L, Huang H, Liu Z, Ruan J, Xu C
Front Nutr. 2023; 10:1162079.
PMID: 37255941
PMC: 10226647.
DOI: 10.3389/fnut.2023.1162079.
NAFLD, MAFLD, and beyond: one or several acronyms for better comprehension and patient care.
Portincasa P
Intern Emerg Med. 2023; 18(4):993-1006.
PMID: 36807050
PMC: 10326150.
DOI: 10.1007/s11739-023-03203-0.
The association of dietary and lifestyle indices for hyperinsulinemia with odds of non-alcoholic fatty liver disease in Iranian adults: a case-control study.
Momeni A, Haghshenas R, Jahromi S
BMC Nutr. 2023; 9(1):16.
PMID: 36670457
PMC: 9854092.
DOI: 10.1186/s40795-023-00675-3.
Association between Sarcopenic Obesity Status and Nonalcoholic Fatty Liver Disease and Fibrosis.
Song W, Yoo S, Jang J, Baik S, Lee B, Lee H
Gut Liver. 2022; 17(1):130-138.
PMID: 36472070
PMC: 9840924.
DOI: 10.5009/gnl220041.
Systemic immune-inflammation index is associated with hepatic steatosis: Evidence from NHANES 2015-2018.
Song Y, Guo W, Li Z, Guo D, Li Z, Li Y
Front Immunol. 2022; 13:1058779.
PMID: 36466832
PMC: 9718528.
DOI: 10.3389/fimmu.2022.1058779.
Tirzepatide for the treatment of adults with type 2 diabetes: An endocrine perspective.
De Block C, Bailey C, Wysham C, Hemmingway A, Allen S, Peleshok J
Diabetes Obes Metab. 2022; 25(1):3-17.
PMID: 35929488
PMC: 10087310.
DOI: 10.1111/dom.14831.
Effect of Probiotics on Liver Enzymes in Patients With Non-alcoholic Fatty Liver Disease: An Umbrella of Systematic Review and Meta-Analysis.
Musazadeh V, Roshanravan N, Dehghan P, Ahrabi S
Front Nutr. 2022; 9:844242.
PMID: 35677540
PMC: 9169800.
DOI: 10.3389/fnut.2022.844242.
Hydroxytyrosol Promotes the Mitochondrial Function through Activating Mitophagy.
Dong Y, Yu M, Wu Y, Xia T, Wang L, Song K
Antioxidants (Basel). 2022; 11(5).
PMID: 35624756
PMC: 9138034.
DOI: 10.3390/antiox11050893.
Awareness, management, and practice patterns of pediatric NAFLD by primary care physicians.
Lee-Kim V, Morkem R, Barber D, Flemming J, Kehar M
Paediatr Child Health. 2022; 27(2):93-98.
PMID: 35599680
PMC: 9113856.
DOI: 10.1093/pch/pxab057.
Cardiometabolic disorders, inflammation and the incidence of non-alcoholic fatty liver disease: A longitudinal study comparing lean and non-lean individuals.
Aneni E, Saeed G, Bittencourt M, Cainzos-Achirica M, Osondu C, Budoff M
PLoS One. 2022; 17(4):e0266505.
PMID: 35385529
PMC: 8985996.
DOI: 10.1371/journal.pone.0266505.
Machine learning using longitudinal prescription and medical claims for the detection of non-alcoholic steatohepatitis (NASH).
Yasar O, Long P, Harder B, Marshall H, Bhasin S, Lee S
BMJ Health Care Inform. 2022; 29(1).
PMID: 35354641
PMC: 8968511.
DOI: 10.1136/bmjhci-2021-100510.
Alterations in DNA methylation associate with fatty liver and metabolic abnormalities in a multi-ethnic cohort of pre-teenage children.
Moylan C, Mavis A, Jima D, Maguire R, Bashir M, Hyun J
Epigenetics. 2022; 17(11):1446-1461.
PMID: 35188871
PMC: 9586600.
DOI: 10.1080/15592294.2022.2039850.